SEARCH

SEARCH BY CITATION

References

  • 1
    The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European network for understanding mechanisms of severe asthma. Eur Respir J 2003;22:470477.
  • 2
    Wenzel S. Mechanisms of severe asthma. Clin Exp Allergy 2003;33:16221628.
  • 3
    Lodrup Carlsen KC, Haland G, Devulapalli CS, Munthe-Kaas M, Pettersen M, Granum B et al. Asthma in every fifth child in Oslo, Norway: a 10-year follow up of a birth cohort study. Allergy 2006;61:454460.
  • 4
    Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998;351:12251232.
  • 5
    Burney PG, Luczynska C, Chinn S, Jarvis D. The European Community Respiratory Health Survey. Eur Respir J 1994;7:954960.
  • 6
    Walsh LJ, Wong CA, Cooper S, Guhan AR, Pringle M, Tattersfield AE. Morbidity from asthma in relation to regular treatment: a community based study. Thorax 1999;54:296300.
  • 7
    Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000;16:802807.
  • 8
    National Heart Lung and Blood Institute. Global initiative for asthma. Bethesda, MD: National Institutes of Health, 2006.
  • 9
    Liard R, Leynaert B, Zureik M, Beguin FX, Neukirch F. Using global initiative for sthma guidelines to assess asthma severity in populations. Eur Respir J 2000;16:615620.
  • 10
    Fuhlbrigge AL. Asthma severity and asthma control: symptoms, pulmonary function, and inflammatory markers. Curr Opin Pulm Med 2004;10:16.
  • 11
    Cockcroft DW, Swystun VA. Asthma control versus asthma severity. J Allergy Clin Immunol 1996;98(6 pt 1):10161018.
  • 12
    Chung KF, Godard P, Adelroth E, Ayres J, Barnes N, Barnes P et al. Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society. Eur Respir J 1999;13:11981208.
  • 13
    Lodrup Carlsen KC, Magnus P, Carlsen KH. Lung function by tidal breathing in awake healthy newborn infants. Eur Respir J 1994;7:16601668.
  • 14
    Devulapalli CS, Haaland G, Pettersen M, Carlsen KH, Lodrup Carlsen KC. Effect of inhaled steroids on lung function in young children: a cohort study. Eur Respir J 2004;23:869875.
  • 15
    Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993;16:540.
  • 16
    Zapletal A, Samanek M, Paul T Lung function in children and adolescents. Methods, reference values. Prog Respir Res 1987;22:113218.
  • 17
    Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG et al. Guidelines for methacholine and exercise challenge testing – 1999. Am J Respir Crit Care Med 2000;161:309329.
  • 18
    Haland G, Carlsen KC, Sandvik L, Devulapalli CS, Munthe-Kaas MC, Pettersen M et al. Reduced lung function at birth and the risk of asthma at 10 years of age. N Engl J Med 2006;355:16821689.
  • 19
    Carlsen KH, Engh G, Mork M. Exercise-induced bronchoconstriction depends on exercise load. Respir Med 2000;94:750755.
  • 20
    Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children – 1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 1999;160:21042117.
  • 21
    Devulapalli CS, Carlsen KC, Haland G, Munthe-Kaas MC, Pettersen M, Mowinckel P et al. Severity of obstructive airways disease by age 2 years predicts asthma at 10 years of age. Thorax 2008;63:813.
  • 22
    Robinson DS, Campbell DA, Durham SR, Pfeffer J, Barnes PJ, Chung KF. Systematic assessment of difficult-to-treat asthma. Eur Respir J 2003;22:478483.
  • 23
    Ranganathan SC, Payne DN, Jaffe A, McKenzie SA. Difficult asthma: defining the problems. Pediatr Pulmonol 2001;31:114120.
  • 24
    De Blic J, Tillie-Leblond I, Tonnel AB, Jaubert F, Scheinmann P, Gosset P. Difficult asthma in children: an analysis of airway inflammation. J Allergy Clin Immunol 2004;113:94100.
  • 25
    Fitzpatrick AM, Gaston BM, Erzurum SC, Teague WG. Features of severe asthma in school-age children: atopy and increased exhaled nitric oxide. J Allergy Clin Immunol 2006;118:12181225.
  • 26
    Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med 2000;162:23412351.
  • 27
    Jenkins HA, Cherniack R, Szefler SJ, Covar R, Gelfand EW, Spahn JD. A comparison of the clinical characteristics of children and adults with severe asthma. Chest 2003;124:13181324.
  • 28
    Chipps BE, Szefler SJ, Simons FE, Haselkorn T, Mink DR, Deniz Y et al. Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthma. J Allergy Clin Immunol 2007;119:11561163.
  • 29
    Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 2004;114:4047.
  • 30
    Ramsey CD, Celedon JC, Sredl DL, Weiss ST, Cloutier MM. Predictors of disease severity in children with asthma in Hartford, Connecticut. Pediatr Pulmonol 2005;39:268275.
  • 31
    Lucas SR, Platts-Mills TA. Paediatric asthma and obesity. Paediatr Respir Rev 2006;7:233238.
  • 32
    Siroux V, Oryszczyn MP, Paty E, Kauffmann F, Pison C, Vervloet D et al. Relationships of allergic sensitization, total immunoglobulin E and blood eosinophils to asthma severity in children of the EGEA Study. Clin Exp Allergy 2003;33:746751.
  • 33
    Gaga M, Papageorgiou N, Yiourgioti G, Karydi P, Liapikou A, Bitsakou H et al. Risk factors and characteristics associated with severe and difficult to treat asthma phenotype: an analysis of the ENFUMOSA group of patients based on the ECRHS questionnaire. Clin Exp Allergy 2005;35:954959.
  • 34
    Pearce N, Pekkanen J, Beasley R. How much asthma is really attributable to atopy? Thorax 1999;54:268272.
  • 35
    Ponsonby AL, Gatenby P, Glasgow N, Mullins R, McDonald T, Hurwitz M. Which clinical subgroups within the spectrum of child asthma are attributable to atopy? Chest 2002;121:135142.